Hiroyuki Matsuda (Q141656): Difference between revisions
From geokb
(Created a new Item: Person record added from ORCID registry based on ORCID ID found as author/contributor to USGS publication) |
(Changed an Item: removed superfluous reference from instance of claim) |
||||||||||||||
(3 intermediate revisions by the same user not shown) | |||||||||||||||
Property / instance of: person / reference | |||||||||||||||
Property / ORCID iD: 0000-0003-3580-8483 / reference | |||||||||||||||
Property / OpenAlex ID | |||||||||||||||
Property / OpenAlex ID: A5021979476 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / OpenAlex ID: A5021979476 / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / OpenAlex ID: A5021979476 / qualifier | |||||||||||||||
retrieved: 29 August 2024
| |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Supercritical Fluid Extraction and Processing / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Supercritical Fluid Extraction and Processing / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Supercritical Fluid Extraction and Processing / qualifier | |||||||||||||||
prevalence: 49
| |||||||||||||||
Property / knows about: Supercritical Fluid Extraction and Processing / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Properties of Liquid Mixtures in Thermodynamics / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Properties of Liquid Mixtures in Thermodynamics / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Properties of Liquid Mixtures in Thermodynamics / qualifier | |||||||||||||||
prevalence: 38
| |||||||||||||||
Property / knows about: Properties of Liquid Mixtures in Thermodynamics / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Preoperative Chemoradiotherapy for Esophageal Cancer / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Preoperative Chemoradiotherapy for Esophageal Cancer / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Preoperative Chemoradiotherapy for Esophageal Cancer / qualifier | |||||||||||||||
prevalence: 30
| |||||||||||||||
Property / knows about: Preoperative Chemoradiotherapy for Esophageal Cancer / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Thermochemical Properties of Organic Compounds / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Thermochemical Properties of Organic Compounds / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Thermochemical Properties of Organic Compounds / qualifier | |||||||||||||||
prevalence: 27
| |||||||||||||||
Property / knows about: Thermochemical Properties of Organic Compounds / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Advancements in Lung Cancer Research / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Advancements in Lung Cancer Research / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Advancements in Lung Cancer Research / qualifier | |||||||||||||||
prevalence: 22
| |||||||||||||||
Property / knows about: Advancements in Lung Cancer Research / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Focused Ultrasound Technology and Applications / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Focused Ultrasound Technology and Applications / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Focused Ultrasound Technology and Applications / qualifier | |||||||||||||||
prevalence: 14
| |||||||||||||||
Property / knows about: Focused Ultrasound Technology and Applications / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Gastric Cancer Research and Treatment / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Gastric Cancer Research and Treatment / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Gastric Cancer Research and Treatment / qualifier | |||||||||||||||
prevalence: 14
| |||||||||||||||
Property / knows about: Gastric Cancer Research and Treatment / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Chiral Separation in Chromatography / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Chiral Separation in Chromatography / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Chiral Separation in Chromatography / qualifier | |||||||||||||||
prevalence: 14
| |||||||||||||||
Property / knows about: Chiral Separation in Chromatography / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Applications of Ionic Liquids / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Applications of Ionic Liquids / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Applications of Ionic Liquids / qualifier | |||||||||||||||
prevalence: 13
| |||||||||||||||
Property / knows about: Applications of Ionic Liquids / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Asthma / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Asthma / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Asthma / qualifier | |||||||||||||||
prevalence: 13
| |||||||||||||||
Property / knows about: Asthma / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Molecular Mechanisms of Cardiac Arrhythmias / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Molecular Mechanisms of Cardiac Arrhythmias / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Molecular Mechanisms of Cardiac Arrhythmias / qualifier | |||||||||||||||
prevalence: 13
| |||||||||||||||
Property / knows about: Molecular Mechanisms of Cardiac Arrhythmias / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Aqueous Two-Phase Systems in Separation Science / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Aqueous Two-Phase Systems in Separation Science / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Aqueous Two-Phase Systems in Separation Science / qualifier | |||||||||||||||
prevalence: 12
| |||||||||||||||
Property / knows about: Aqueous Two-Phase Systems in Separation Science / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Membrane Gas Separation Technology / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Membrane Gas Separation Technology / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Membrane Gas Separation Technology / qualifier | |||||||||||||||
prevalence: 11
| |||||||||||||||
Property / knows about: Membrane Gas Separation Technology / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Esophageal Intervention Techniques / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Esophageal Intervention Techniques / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Esophageal Intervention Techniques / qualifier | |||||||||||||||
prevalence: 11
| |||||||||||||||
Property / knows about: Esophageal Intervention Techniques / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Molecular Mechanisms of Ion Channels Regulation / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Molecular Mechanisms of Ion Channels Regulation / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Molecular Mechanisms of Ion Channels Regulation / qualifier | |||||||||||||||
prevalence: 11
| |||||||||||||||
Property / knows about: Molecular Mechanisms of Ion Channels Regulation / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: State-of-the-Art in Process Optimization under Uncertainty / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: State-of-the-Art in Process Optimization under Uncertainty / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: State-of-the-Art in Process Optimization under Uncertainty / qualifier | |||||||||||||||
prevalence: 10
| |||||||||||||||
Property / knows about: State-of-the-Art in Process Optimization under Uncertainty / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Idiopathic Pulmonary Fibrosis: Diagnosis and Management / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Idiopathic Pulmonary Fibrosis: Diagnosis and Management / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Idiopathic Pulmonary Fibrosis: Diagnosis and Management / qualifier | |||||||||||||||
prevalence: 10
| |||||||||||||||
Property / knows about: Idiopathic Pulmonary Fibrosis: Diagnosis and Management / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Advancements in Colorectal Cancer Research / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Advancements in Colorectal Cancer Research / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Advancements in Colorectal Cancer Research / qualifier | |||||||||||||||
prevalence: 10
| |||||||||||||||
Property / knows about: Advancements in Colorectal Cancer Research / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Natural Killer Cells in Immunity / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Natural Killer Cells in Immunity / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Natural Killer Cells in Immunity / qualifier | |||||||||||||||
prevalence: 10
| |||||||||||||||
Property / knows about: Natural Killer Cells in Immunity / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Crystallization Processes and Control / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Crystallization Processes and Control / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Crystallization Processes and Control / qualifier | |||||||||||||||
prevalence: 10
| |||||||||||||||
Property / knows about: Crystallization Processes and Control / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Small Cell Lung Cancer / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Small Cell Lung Cancer / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Small Cell Lung Cancer / qualifier | |||||||||||||||
prevalence: 9
| |||||||||||||||
Property / knows about: Small Cell Lung Cancer / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Hepatocellular Carcinoma / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Hepatocellular Carcinoma / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Hepatocellular Carcinoma / qualifier | |||||||||||||||
prevalence: 9
| |||||||||||||||
Property / knows about: Hepatocellular Carcinoma / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Cancer Immunotherapy / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Cancer Immunotherapy / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Cancer Immunotherapy / qualifier | |||||||||||||||
prevalence: 9
| |||||||||||||||
Property / knows about: Cancer Immunotherapy / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Diagnosis and Treatment of Lung Cancer / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Diagnosis and Treatment of Lung Cancer / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Diagnosis and Treatment of Lung Cancer / qualifier | |||||||||||||||
prevalence: 9
| |||||||||||||||
Property / knows about: Diagnosis and Treatment of Lung Cancer / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Lymphoid Neoplasms / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Lymphoid Neoplasms / qualifier | |||||||||||||||
last update: 24 August 2024
| |||||||||||||||
Property / knows about: Lymphoid Neoplasms / qualifier | |||||||||||||||
prevalence: 9
| |||||||||||||||
Property / knows about: Lymphoid Neoplasms / reference | |||||||||||||||
Property / employer | |||||||||||||||
Property / employer: Nihon University / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / employer: Nihon University / qualifier | |||||||||||||||
point in time: 2023
| |||||||||||||||
Property / employer: Nihon University / reference | |||||||||||||||
Latest revision as of 22:15, 22 September 2024
a record for a person added from ORCID based on a contributor to a USGS publication
Language | Label | Description | Also known as |
---|---|---|---|
English | Hiroyuki Matsuda |
a record for a person added from ORCID based on a contributor to a USGS publication |
Statements
24 August 2024
49
1 reference
24 August 2024
38
1 reference
24 August 2024
30
1 reference
24 August 2024
27
1 reference
24 August 2024
22
1 reference
24 August 2024
14
1 reference
24 August 2024
14
1 reference
24 August 2024
14
1 reference
24 August 2024
13
1 reference
24 August 2024
13
1 reference
24 August 2024
13
1 reference
24 August 2024
12
1 reference
24 August 2024
11
1 reference
24 August 2024
11
1 reference
24 August 2024
11
1 reference
24 August 2024
10
1 reference
24 August 2024
10
1 reference
24 August 2024
10
1 reference
24 August 2024
10
1 reference
24 August 2024
10
1 reference
24 August 2024
1 reference
24 August 2024
1 reference
24 August 2024
1 reference
24 August 2024
1 reference
24 August 2024
1 reference